SEC Filings TLDR

On October 23, 2025, POTBELLY CORP (PBPB) completed a merger with RaceTrac, Inc., resulting in POTBELLY becoming a wholly owned subsidiary of RaceTrac. Each share of POTBELLY's common stock was converted into the right to receive $17.12 per share in cash. Robert D. Wright, the President and CEO of POTBELLY, disposed of...

Vann A. Avedisian, a director of Potbelly Corp, disposed of a significant number of shares and warrants in the company on October 23, 2025. The transactions were part of the merger agreement between Potbelly Corp, RaceTrac, Inc., and Hero Sub Inc. Avedisian disposed of 96,930 shares of common stock directly, 513,163 sh...

On October 23, 2025, David T. Pearson, a director of Potbelly Corp, disposed of 49,386 shares of common stock at a price of $17.12 per share. This transaction was part of the merger agreement between Potbelly Corp, RaceTrac, Inc., and Hero Sub Inc. The merger resulted in the automatic cancellation and conversion of eac...

David W. Head, a director of Potbelly Corp, disposed of 147,726 shares of common stock on October 23, 2025, at a price of $17.12 per share. This transaction was part of the merger agreement between Potbelly Corp, RaceTrac, Inc., and Hero Sub Inc., where each share of common stock was converted into the right to receive...

On October 23, 2025, David Near, a director of Potbelly Corp, disposed of 158,840 shares of common stock at a price of $17.12 per share. This transaction was part of the merger agreement between Potbelly Corp, RaceTrac, Inc., and Hero Sub Inc. The merger resulted in the automatic cancellation and conversion of each sha...

On October 23, 2025, Adam Noyes, Senior Vice President and Chief Operating Officer of Potbelly Corp, disposed of 395,024 shares of common stock at $17.12 per share, resulting in total proceeds of approximately $6.76 million. This transaction occurred following the merger of Potbelly Corp with RaceTrac, Inc., where each...

On October 23, 2025, OrbiMed Advisors LLC and OrbiMed Capital GP V LLC, both ten percent owners of PMV Pharmaceuticals, Inc., sold 1,000,000 shares of common stock at a price of $1.52 per share. Following the transaction, the entities collectively own 4,975,291 shares. The securities are held by OrbiMed Private Investm...

On October 24, 2025, Alejandro T. Vallejo, EVP and Chief People Officer of PG&E Corp, acquired 487.55 units of phantom stock at a price of $16.40 per share. This transaction increased his total holdings of phantom stock to 28,578.75 units. The phantom stock is the economic equivalent of one share of common stock and be...

On October 23, 2025, Leon Trefler, Chief of Clients and Markets at Pegasystems Inc., engaged in multiple transactions involving the company's common stock. Trefler acquired 30,590 shares at $12.60 per share, increasing his holdings to 149,389 shares. He also disposed of 15,725 shares at $63.40 per share, reducing his h...

Efstathios A. Kouninis, SVP and Chief Accounting Officer of Pegasystems Inc., reported several transactions involving the company's common stock on October 23, 2025. Kouninis acquired 8,006 shares at $22.15 per share, resulting in a total of 8,212 shares post-transaction. He also disposed of 4,013 shares at $65.50 per ...

On October 24, 2025, Anthony M. Sharett, President of Pathward Financial, Inc., sold 11,500 shares of the company's common stock at a weighted average price of $71.55 per share. The shares were sold in multiple transactions at prices ranging from $71.20 to $71.77. Following this transaction, Sharett owns 25,155 shares ...

Steven T. Warshaw, a director of Park Aerospace Corp., reported transactions involving the company's common stock and options. On October 24, 2025, Warshaw acquired 3,000 shares of common stock at $5.23 per share, increasing his total holdings to 13,750 shares. Additionally, he disposed of 3,000 options to buy common s...

On October 23, 2025, Helm Robert F, the EVP/CFO of Ollie's Bargain Outlet Holdings, Inc., sold 367 shares of the company's common stock at a price of $120.08 per share. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 19, 2024, and disclosed in the issuer's Form 10-K filed on March 2...

Douglas A. Kehring, EVP and Principal Financial Officer of Oracle Corp, received 60,700 restricted stock units (RSUs) on October 23, 2025. Each RSU represents the contingent right to receive one share of common stock upon settlement. The RSUs will vest in four equal annual installments, starting on the first anniversar...

Lawrence J. Ellison, Executive Chairman and Chief Technology Officer of Oracle Corp, was granted 571,286 stock options on October 23, 2025. The options have an exercise price of $280.07 and will expire on October 23, 2035. The options vest annually, with 25% of the shares vesting each year on the anniversary of the gra...

Mark Hura, President of Global Field Operations at Oracle Corp, was granted 428,465 stock options on October 23, 2025. The options have an exercise price of $280.07 and will expire on October 23, 2035. The shares vest annually at 25% per year starting from the grant date. This transaction was reported under Form 4, ind...

Jeffrey Henley, Vice Chairman of Oracle Corp, was granted 32,135 restricted stock units (RSUs) on October 23, 2025. Each RSU represents the right to receive one share of Oracle's common stock upon settlement. The RSUs vest in four equal annual installments, starting one year after the grant date. This transaction was r...

Safra Catz, Chief Executive Officer of Oracle Corp, received 32,135 restricted stock units (RSUs) on October 23, 2025. Each RSU represents the contingent right to receive one share of common stock upon settlement. The RSUs vest in four equal annual installments, starting on the first anniversary of the grant date. This...

Maria Smith, EVP and Chief Accounting Officer at Oracle Corp, was granted 35,706 restricted stock units (RSUs) on October 23, 2025. Each RSU represents the contingent right to receive one share of common stock upon settlement. The RSUs vest in four equal annual installments, starting on the first anniversary of the gra...

On October 23, 2025, Stuart Levey, EVP and Chief Legal Officer of Oracle Corp, acquired 142.94 restricted stock units (RSUs) at a price of $280.07 per share, representing dividend equivalents accrued on previously granted RSUs. Additionally, he acquired 49,988 RSUs at $0 per share, which vest in four equal annual insta...

Jason A. Zampi, EVP & CFO of Norfolk Southern Corp, engaged in several stock transactions on October 24, 2025. He acquired 150 shares of Common Stock at $0 per share, increasing his holdings to 3,067 shares. Additionally, he disposed of 42 shares at $282.50 per share, reducing his holdings to 3,025 shares. Furthermore,...

Anil Bhatt, EVP & CIDO of Norfolk Southern Corp, reported several equity transactions on October 24, 2025. These included the acquisition of 3,259 and 220 shares of Common Stock at $0 per share, increasing his holdings to 3,259 and 3,479 shares respectively. Additionally, he disposed of 60 and 1,106 shares of Common St...

On October 20, 2025, Michael D. Farkas, the CEO and Executive Chairman of NextNRG, Inc., acquired 21,739 shares of the company's common stock at a price of $1.83 per share. This transaction increased his total holdings to 75,276,039 shares. The shares were issued as a dividend on Series B Preferred Shares held by Farka...

Manuel Bronstein, a director of The New York Times Company, has granted a power of attorney to several individuals, including Michael A. Brown, to act on his behalf in matters related to SEC filings. This includes executing Forms ID, 3, 4, and 5, and managing his EDGAR account. Additionally, Bronstein acquired 54 share...

The filing is a Power of Attorney document executed by Anuradha B. Subramanian, a director of The New York Times Company. The document appoints several individuals as attorneys-in-fact to act on behalf of Subramanian in matters related to SEC filings, including Forms ID, 3, 4, and 5, as well as other actions necessary ...